Biomarkers in cardiovascular medicine

Area of Science:

• Cardiology
• Biomarker Discovery

Background:

• Cardiovascular disease is a leading cause of death globally.
• Atherosclerotic plaque and thrombus formation underlie conditions like heart attack and stroke.
• Accurate prediction of thrombotic events is a major clinical challenge.

Purpose of the Study:

• To review the current state of diagnostic and prognostic biomarkers for cardiovascular events.
• To highlight the potential of emerging technologies in discovering new predictive markers.
• To discuss the future integration of novel biomarkers with imaging for improved risk assessment.

Main Methods:

• Review of existing literature on cardiovascular biomarkers.
• Discussion of established biomarkers such as C-reactive protein and soluble CD40 ligand.
• Exploration of high-performance techniques like proteomics for multi-biomarker detection.

Main Results:

• No single biomarker is currently universally accepted for clinical use in predicting cardiovascular events.
• Existing biomarkers like C-reactive protein and soluble CD40 ligand offer some predictive value.
• Proteomics and other advanced techniques show promise for identifying novel biomarkers.

Conclusions:

• There is a critical need for improved methods to predict acute thrombotic events.
• Proteomics and advanced molecular techniques are expected to yield new cardiovascular biomarkers.
• Future advancements may combine novel biomarkers with imaging for enhanced risk stratification.